Discovering the next generation of breakthrough drugs

Our mission is to build the leading AI-enabled biotech company that accelerates the discovery and development of life-saving therapeutics to make a meaningful impact on the lives of patients. Aitia makes this possible by revealing the hidden biological mechanisms of disease with the power of causal AI, multi-omic patient data, and our resulting Gemini Digital Twins.

AI Approaches Poised to Disrupt New Areas of Drug Discovery

Our AI approaches are poised to disrupt new areas of drug discovery, unlocking the potential to discover the next generation of breakthrough drugs by creating Gemini Digital Twins of human disease from multi-omic patient data.

AI-Driven Pipeline of First-in-Kind Programs

Aitia’s pipeline of differentiated, novel partnered programs in oncology and neurodegenerative diseases to address the rapid, devastating impacts they have on patients and their families

Our First-in-class Team

We are a world-class team of AI pioneers, R&D veterans, and biotech company builders backed by top-tier healthcare and strategic pharma leaders working toward our shared mission.

Strategic Partnerships in AI-enabled Drug Discovery

We collaborate with industry-leading companies across diverse therapeutic areas to lead the way in discovering breakthrough therapies.

Discovering the next generation of breakthrough drugs

AI Approaches Poised to Disrupt New Areas of Drug Discovery

AI-Driven Pipeline of First-in-Kind Programs

Our First-in-class Team

Strategic Partnerships in AI-enabled Drug Discovery

Join the Future of Biotech: Your Opportunity to Shape Tomorrow's Discoveries

Press Release

In the News

Events